
Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

